13F Holdings
中文EN

SRTS Sensus Healthcare, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1494891 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-53.3%
TTM net income YoY-433.4%
TTM EPS YoY-438.9%
Revenue 3-yr CAGR-12.7%
Net income 3-yr CAGR—

Margins

Gross margin41.8%
Operating margin-74.0%
Net margin-96.5%
FCF margin-69.4%
EBITDA margin-71.9%

Returns

ROE-37.0%
ROA-32.4%
ROIC (approx.)-39.5%
Asset turnover0.34x

Leverage & solvency

Liabilities / assets12.6%
Debt / equity0.00x
Current ratio6.77x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.71x
Accruals ratio-9.5%
Payout ratio—
Capex / revenue1.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$27.48M$41.81M$24.41M$44.53M$27.04M
Cost of revenue$15.62M$17.38M$10.35M$14.90M$10.05M
Gross profit$11.87M$24.43M$14.06M$29.63M$16.99M
R&D expense$7.78M$4.22M$3.68M$3.46M$3.44M
SG&A expense$7.87M$7.15M$5.16M$5.01M$4.59M
Operating income-$10.31M$8.09M-$382,000$14.83M$4.12M
Interest expense—-$932,000-$992,000-$380,000$2,000
Pretax income-$9.62M$9.02M$652,000$27.99M$4.12M
Income tax-$1.91M$2.38M$167,000$3.75M—
Net income-$7.72M$6.65M$485,000$24.24M$4.12M
EBITDA-$9.91M$8.29M-$107,000$15.15M$4.73M
EPS (basic)-0.470.410.031.470.25
EPS (diluted)-0.470.410.031.460.25
Weighted avg. shares (diluted)16.33M16.36M16.27M16.62M16.50M
Banking
Net interest income$683,000$932,000———
Balance sheet
Cash & equivalents$22.08M$22.06M$23.15M$25.52M$14.52M
Receivables$6.04M$19.73M$10.64M$17.30M$12.13M
Inventory$14.56M$10.10M$11.86M$3.50M$1.76M
Current assets$45.89M$56.74M$49.53M$53.24M$31.25M
PP&E, net$1.98M$2.00M$464,000$243,000$605,000
Intangibles———$50,000$146,000
Total assets$53.04M$62.16M$53.71M$56.73M$32.24M
Current liabilities$4.72M$5.88M$4.21M$7.70M$5.96M
Total liabilities$4.94M$6.34M$4.87M$8.67M$6.22M
Shareholders' equity$48.10M$55.83M$48.84M$48.07M$26.02M
Shares outstanding16.46M16.50M16.37M16.39M16.62M
Cash flow statement
Operating cash flow$528,000-$831,000-$2.15M-$1.41M-$286,000
Capital expenditure$196,000$276,000$229,000$159,000$128,000
Free cash flow$332,000-$1.11M-$2.37M-$1.57M-$414,000
Investing cash flow-$196,000-$276,000-$187,000$14.84M$129,000
Financing cash flow-$305,000$15,000-$40,000-$2.43M-$231,000
Depreciation & amortization$400,000$200,000$275,000$315,000$613,000
Stock-based compensation$295,000$323,000$328,000$187,000$415,000
Share buybacks$300,000—$27,000$3.00M—

Free plan shows the latest 5 periods; Pro shows all 11 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.